These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27591678)

  • 1. Epstein Barr virus - a tumor virus that needs cytotoxic lymphocytes to persist asymptomatically.
    Münz C
    Curr Opin Virol; 2016 Oct; 20():34-39. PubMed ID: 27591678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune escape by Epstein-Barr virus associated malignancies.
    Münz C; Moormann A
    Semin Cancer Biol; 2008 Dec; 18(6):381-7. PubMed ID: 18996483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy for Epstein-Barr virus-associated malignancies.
    Long HM; Parsonage G; Fox CP; Lee SP
    Drug News Perspect; 2010 May; 23(4):221-8. PubMed ID: 20520851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity in Epstein Barr virus specific immune control.
    Münz C
    Curr Opin Virol; 2021 Feb; 46():1-8. PubMed ID: 32771660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment options for post-transplant lymphoproliferative disorder and other Epstein-Barr virus-associated malignancies.
    Davis JE; Moss DJ
    Tissue Antigens; 2004 Apr; 63(4):285-92. PubMed ID: 15009802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV-associated lymphomas in adults.
    Roschewski M; Wilson WH
    Best Pract Res Clin Haematol; 2012 Mar; 25(1):75-89. PubMed ID: 22409825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T cell responses in the immune control against latent infection by Epstein-Barr virus.
    Paludan C; Münz C
    Curr Mol Med; 2003 Jun; 3(4):341-7. PubMed ID: 12776989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
    Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
    mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of Epstein-Barr virus infection.
    Hiraki A; Fujii N; Masuda K; Ikeda K; Tanimoto M
    Biomed Pharmacother; 2001 Sep; 55(7):369-72. PubMed ID: 11669499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for Epstein-Barr virus-associated cancers in children.
    Straathof KC; Bollard CM; Rooney CM; Heslop HE
    Oncologist; 2003; 8(1):83-98. PubMed ID: 12604735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus: the first human tumor virus and its role in cancer.
    Pagano JS
    Proc Assoc Am Physicians; 1999; 111(6):573-80. PubMed ID: 10591086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBV-Directed T Cell Therapeutics for EBV-Associated Lymphomas.
    McLaughlin LP; Gottschalk S; Rooney CM; Bollard CM
    Methods Mol Biol; 2017; 1532():255-265. PubMed ID: 27873282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
    Longnecker R
    Adv Cancer Res; 2000; 79():175-200. PubMed ID: 10818681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-associated lymphoproliferative disorders.
    Grywalska E; Markowicz J; Grabarczyk P; Pasiarski M; Roliński J
    Postepy Hig Med Dosw (Online); 2013 May; 67():481-90. PubMed ID: 23752600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus--associated diseases in humans.
    Kawa K
    Int J Hematol; 2000 Feb; 71(2):108-17. PubMed ID: 10745621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination against the Epstein-Barr virus.
    Rühl J; Leung CS; Münz C
    Cell Mol Life Sci; 2020 Nov; 77(21):4315-4324. PubMed ID: 32367191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological aspects of Epstein-Barr virus (EBV)-infected lymphocytes in chronic active EBV infection and associated malignancies.
    Kanegane H; Nomura K; Miyawaki T; Tosato G
    Crit Rev Oncol Hematol; 2002 Dec; 44(3):239-49. PubMed ID: 12467964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Epstein-Barr virus and its association with human cancers.
    Baumforth KR; Young LS; Flavell KJ; Constandinou C; Murray PG
    Mol Pathol; 1999 Dec; 52(6):307-22. PubMed ID: 10748864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
    Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM
    J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.